Published in Am J Med on February 08, 2013
Antinuclear antibody test: when to order? Am J Med (2013) 1.16
Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. J Immunol Res (2014) 1.03
Clinical and serological features of patients referred through a rheumatology triage system because of positive antinuclear antibodies. PLoS One (2014) 0.86
Automated tests of ANA immunofluorescence as throughput autoantibody detection technology: strengths and limitations. BMC Med (2014) 0.84
The significance of autoantibodies to DFS70/LEDGFp75 in health and disease: integrating basic science with clinical understanding. Clin Exp Med (2015) 0.83
Specificity of antinuclear autoantibodies recognizing the dense fine speckled nuclear pattern: Preferential targeting of DFS70/LEDGFp75 over its interacting partner MeCP2. Clin Immunol (2015) 0.80
How should a district general hospital immunology service screen for anti-nuclear antibodies? An 'in-the-field' audit. Clin Exp Immunol (2015) 0.79
Biomarkers of mercury exposure in the Amazon. Biomed Res Int (2014) 0.77
Antinuclear antibody testing - misunderstood or misbegotten? Nat Rev Rheumatol (2017) 0.76
Antinuclear antibody testing: discordance between commercial laboratories. Clin Rheumatol (2016) 0.76
The prevalence of antinuclear antibodies in patients with schizophrenia spectrum disorders: results from a large cohort study. NPJ Schizophr (2015) 0.75
The reply. Am J Med (2013) 0.75
Anti-nuclear antibodies in daily clinical practice: prevalence in primary, secondary, and tertiary care. J Immunol Res (2014) 0.75
Next-Generation Autoantibody Testing by Combination of Screening and Confirmation-the CytoBead® Technology. Clin Rev Allergy Immunol (2017) 0.75
Translating epigenetics into clinic: focus on lupus. Clin Epigenetics (2017) 0.75
Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial. Arthritis Rheum (2002) 1.62
Narrative review: the pathophysiology of fibromyalgia. Ann Intern Med (2007) 1.56
Diagnosis, treatment, and prognosis of erythema migrans and Lyme arthritis. Clin Dermatol (2006) 0.92
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial: lessons learned. Semin Arthritis Rheum (2004) 0.85
A 58-year-old man with anti-Jo-1 syndrome and renal cell carcinoma: a case report and discussion. Conn Med (2007) 0.79
Fibromyalgia remains a controversial medical enigma. Am Fam Physician (2008) 0.76
The reply. Am J Med (2013) 0.75
The Vioxx debacle revisited. Am J Med (2005) 0.75
Pregabalin for fibromyalgia. Cleve Clin J Med (2009) 0.75
Use of a medication control officer to reduce bias in a clinical trial: lessons learned from the scleroderma lung study. Clin Trials (2009) 0.75